CARDIFF ONCOLOGY, INC. Other Revenue, Net (Deprecated 2018-01-31)
CARDIFF ONCOLOGY, INC. (CRDF) reported Other Revenue, Net (Deprecated 2018-01-31) of $11.49 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-11-07
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $11.49K, a 78.67% increase year-over-year.
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $20.05K, a 1079.12% increase year-over-year.
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $11.08K, a 3065.43% increase year-over-year.
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $15.37K, a 1082.15% increase year-over-year.
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2017 was $23.85K, a 35.32% decline from fiscal 2016.
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2016 was $36.87K, a 51.27% increase from fiscal 2015.
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $24.38K.
- CARDIFF ONCOLOGY, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $0.00.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-09-30 | $11.49K 10-Q · filed 2018-11-07 | $31.54K derived: sum of 2 quarters · filed 2018-11-07 | $42.61K 10-Q · filed 2018-11-07 | $57.98K derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | $20.05K 10-Q · filed 2018-08-03 | $31.12K 10-Q · filed 2018-08-03 | $46.49K derived: sum of 3 quarters · filed 2018-08-03 | $52.92K derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-03-31 | $11.08K 10-Q · filed 2018-05-08 | $26.45K derived: sum of 2 quarters · filed 2018-05-08 | $32.88K derived: sum of 3 quarters · filed 2018-11-07 | $34.58K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-12-31 | $15.37K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $21.80K derived: sum of 2 quarters · filed 2018-11-07 | $23.50K derived: sum of 3 quarters · filed 2018-11-07 | $23.85K 10-K · filed 2018-02-26 |
| 2017-09-30 | $6.43K 10-Q · filed 2018-11-07 | $8.13K derived: sum of 2 quarters · filed 2018-11-07 | $8.48K 10-Q · filed 2018-11-07 | $9.78K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $1.70K 10-Q · filed 2018-08-03 | $2.05K 10-Q · filed 2018-08-03 | $3.35K derived: sum of 3 quarters · filed 2018-08-03 | $7.25K derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | $350.00 10-Q · filed 2018-05-08 | $1.65K derived: sum of 2 quarters · filed 2018-05-08 | $5.55K derived: sum of 3 quarters · filed 2018-05-08 | $37.22K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $1.30K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $5.20K derived: sum of 2 quarters · filed 2018-02-26 | $36.87K derived: sum of 3 quarters · filed 2018-02-26 | $36.87K 10-K · filed 2018-02-26 |
| 2016-09-30 | $3.90K 10-Q · filed 2017-11-09 | $35.57K derived: sum of 2 quarters · filed 2017-11-09 | $35.57K 10-Q · filed 2017-11-09 | $59.95K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $31.67K 10-Q · filed 2017-08-09 | $31.67K 10-Q · filed 2017-08-09 | $56.05K derived: sum of 3 quarters · filed 2017-08-09 | $56.05K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $24.38K derived: sum of 2 quarters · filed 2017-05-10 | $24.38K derived: sum of 3 quarters · filed 2017-05-10 | $24.38K derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $24.38K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $24.38K derived: sum of 2 quarters · filed 2017-03-15 | $24.38K derived: sum of 3 quarters · filed 2017-03-15 | $24.38K 10-K · filed 2017-03-15 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |